Brief report: Platelet-poor plasma serotonin in autism

Journal of Autism and Developmental Disorders

Volumn 42, Issue 7, 2012, Pages 1510-1514

  Anderson, George M ^a   Hertzig, Margaret E ^b   McBride, P A ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Autism; Hyperserotonemia; Platelet; Platelet poor plasma (PPP); Serotonin

Indexed keywords

SEROTONIN;

ADOLESCENT; ADULT; ARTICLE; AUTISM; CHILD; CHILD BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; MALE; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; THROMBOCYTE POOR PLASMA;

ADOLESCENT; BLOOD PLATELETS; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PLATELET COUNT; REFERENCE VALUES; SEROTONIN; YOUNG ADULT;

EID: 84863860296     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-011-1371-1     Document Type: Article

References (36)

1. Anderson, G. M. (2007). Measurement of plasma serotonin in autism. Pediatric Neurology, 36, 138.
2. Anderson, G. M., Cook, E. H., Jr, & Blakely, R. D. (2009). Serotonin rising. New England Journal of Medicine, 360, 2580.
3. Anderson, G. M., Feibel, F. C., & Cohen, D. J. (1987a). Determination of serotonin in whole blood, PRP, PPP and plasma ultrafiltrate. Life Sciences, 40, 1063-1070. (Pubitemid 17025624)
4. Anderson, G. M., Gutknecht, L., Cohen, D. J., Brailly-Tabard, S., Cohen, J. H., Ferrari, P., et al. (2002). Serotonin transporter promoter variants in autism: Functional effects and relationship to platelet hyperserotonemia. Molecular Psychiatry, 7, 831-836.
5. Anderson, G. M., Minderaa, R. B., Cho, S. C., Volkmar, F. R., &Cohen, D. J. (1989). The issue of hyperserotonemia and platelet serotonin exposure: A preliminary study. Journal of Autism and Developmental Disorders, 19, 349-351.
6. Anderson, G. M., Stevenson, J. M., & Cohen, D. J. (1987b). Steady-state model for plasma free and platelet serotonin in man. Life Sciences, 41, 1777-1785. (Pubitemid 18006405)
7. Beck, O., Wallen, N. H., Broijersen, A., Larsson, P. T., & Hjemdahl, P. (1993). On the accurate determination of serotonin in human plasma. Biochemical Biophysical Research Communications, 196, 260-266. (Pubitemid 23309502)
8. Bonnin, A., Goeden, N., Chen, K., Wilson, M. L., King, J., Shih, J. C., et al. (2011). A transient placental source of serotonin for the fetal forebrain. Nature, 472, 347-350.
9. Brand, T., & Anderson, G. M. (2011). The measurement of platelet-poor plasma serotonin: A systematic review of prior reports and recommendations for improved analysis. Clinical Chemistry, 57, 1376-1386.
10. Bursztejn, C., Ferrari, P., Dreux, C., Braconnier, A., & Lancrenon, S. (1988). Metabolism of serotonin in autism in children. Encephale, 14, 413-419.
11. Buznikov, G. A., Lambert, H. W., & Lauder, J. M. (2001). Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis. Cell Tissue Research, 305, 177-186. (Pubitemid 32681895)
12. Carneiro, A. M., Cook, E. H., Murphy, D. L., & Blakely, R. D. (2008). Interactions between integrin alphaIIbbeta3 and theserotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. Journal of Clinical Investigation, 118, 1544-1552. (Pubitemid 351500447)
13. Chugani, D. C., Muzik, O., Behen, M., Rothermel, R., Janisse, J. J., Lee, J., et al. (1999). Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Annals of Neurology, 45, 287-295. (Pubitemid 29120032)
14. Connors, S. L., Matteson, K. J., Sega, G. A., Lozzio,C. B., Carroll, R. C., & Zimmerman, A. W. (2006). Plasma serotonin in autism. Pediatric Neurology, 35, 182-186. (Pubitemid 44291526)
15. Cook, E., & Leventhal, B. (1996). The serotonin system in autism. Current Opinion in Pediatrics, 8, 348-354.
16. Cook, E. H., Jr, Leventhal, B. L., & Freedman, D. X. (1988). Free serotonin in plasma: Autistic children and their first-degree relatives. Biological Psychiatry, 24, 488-491.
17. Coutinho, A. M., Sousa, I., Martins, M., Correia, C., Morgadinho, T., Bento, C., et al. (2008). Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Human Genetics, 121, 243-256. (Pubitemid 46404458)
18. Croonenberghs, J., Delmeire, L., Verkerk, R., Lin, A. H., Meskal, A., Neels, H., et al. (2000). Peripheral markers of serotonergic and noradrenergic function in post-pubertal caucasian males with autistic disorder. Neuropsychopharmacology, 22, 275-283. (Pubitemid 30089538)
19. Cross, S., Kim, S. J., Weiss, L. A., Delahanty, R. J., Sutcliffe, J. S., Leventhal, B. L., et al. (2008). Molecular genetics of the platelet serotonin system in first-degree relatives of patients with autism. Neuropsychopharmacology, 33, 353-360. (Pubitemid 350243348)
20. Goldberg, J., Anderson, G. M., Zwaigenbaum, L., Hall, G. B., Nahmias, C., Thompson, A., et al. (2009). Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39, 97-104.
21. Hanley, H. G., Stahl, S. M., & Freedman, D. X. (1977). Hyperserotonemia and amine metabolites in autistic and retarded children. Archives of General Psychiatry, 34, 521-531. (Pubitemid 8108951)
22. Hérault, J., Petit, E., Martineau, J., Cherpi, C., Perrot, A., Barthélémy, C., et al. (1996). Serotonin and autism: Biochemical and molecular biology features. Psychiatry Research, 65, 33-43. (Pubitemid 26391623)
23. Launay, J. M., Ferrari, P., Haimart, M., Bursztejn, C., Tabuteau, F., Braconnier, A., et al. (1988). Serotonin metabolism and other biochemical parameters in infantile autism. A controlled study of 22 autistic children. Neuropsychobiology, 20, 1-11. (Pubitemid 19059594)
24. Lesurtel, M., Graf, R., Aleil, B., Walther, D. J., Tian, Y., Jochum, W., et al. (2006). Platelet-derived serotonin mediates liver regeneration. Science, 312(5770), 104-107.
25. Makkonen, I., Riikonen, R., Kokki, H., Airaksinen, M. M., & Kuikka, J. T. (2008). Serotonin and dopamine transporter binding in children with autism determined by SPECT. Developmental Medicine and Child Neurology, 50, 593-597.
26. Martineau, J., Barthélémy, C., Jouve, J., Muh, J. P., & Lelord, G. (1992). Monoamines (serotonin and catecholamines) and their derivatives in infantile autism: Age-related changes and drug effects. Developmental Medicine and Child Neurology, 34, 593-603.
27. McBride, P. A., Anderson, G. M., Hertzig, M. E., Snow, M. E., Thompson, S. M., Khait, V. D., et al. (1998). Effects of diagnosis, race and pubertal status on platelet serotonin levels in autism and mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 767-779.
28. McBride, P. A., Anderson, G. M., Hertzig, M. E., Sweeney, J. A., Kream, J., Cohen, D. J., et al. (1989). Serotonergic responsivity in male young adults with autistic disorder. Archives of General Psychiatry, 46, 205-212.
29. Minderaa, R. B., Anderson, G. M., Volkmar, F. R., Akkerhuis, G. W., & Cohen, D. J. (1987). Urinary 5-hydroxyindoleacetic acid and whole blood serotonin and tryptophan in autistic and normal subjects. Biological Psychiatry, 22, 933-940. (Pubitemid 17095316)
30. Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D., den Boer, J. A., et al. (2004). Platelet serotonin levels in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution, and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 491-499. (Pubitemid 38812390)
31. Mulder, E. J., Anderson, G. M., Kemperman, R. F., Oosterloo-Duinkerken, A., Minderaa, R. B., & Kema, I. P. (2010). Urinary excretion of 5-hydroxyindoleacetic acid, serotonin and 6-sulphatoxymelatonin in normoserotonemic and hyperserotonemic autistic individuals. Neuropsychobiology, 61, 27-32.
32. Murphy, D. G., Daly, E., Schmitz, N., Toal, F., Murphy, K., Curran, S., et al. (2006). Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: An in vivo SPECT study. American Journal of Psychiatry, 163, 934-936. (Pubitemid 44464547)
33. Posey, D. J., Erickson, C. A., & McDougle, C. J. (2008). Developing drugs for core social and communication impairment in autism. Child and Adolescent Psychiatric Clinics of North America, 17, 787-801.
34. Schain, R. J., & Freedman, D. X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. Journal of Pediatrics, 58, 315-320.
35. Spivak, B., Golubchik, P., Mozes, T., Vered, Y., Nechmad, A., Weizman, A., et al. (2004). Low platelet-poor plasma levels of serotonin in adult autistic patients. Neuropsychobiology, 50, 157-160. (Pubitemid 39077836)
36. Vered, Y., Golubchik, P., Mozes, T., Strous, R., Nechmad, A., Mester, R., et al. (2003). The platelet-poor plasma 5-HT response to carbohydrate rich meal administration in adult autistic patients compared with normal controls. Human Psychopharmacology, 18, 395-399. (Pubitemid 36896425)